The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma

Background: Down-expression of microRNA-497 (miR-497) was often found in malignancies. The purposes of this study were to determine the expression of miR-497 in human osteosarcoma and to establish the association between miR-497 expression with cell survival and the sensitivity to cisplatin in human...

Full description

Bibliographic Details
Main Authors: Xue-jun Shao, Mei-hua Miao, Jun Xue, Jian Xue, Xue-qiang Ji, Hong Zhu
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2015-07-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/430172
_version_ 1818309835275370496
author Xue-jun Shao
Mei-hua Miao
Jun Xue
Jian Xue
Xue-qiang Ji
Hong Zhu
author_facet Xue-jun Shao
Mei-hua Miao
Jun Xue
Jian Xue
Xue-qiang Ji
Hong Zhu
author_sort Xue-jun Shao
collection DOAJ
description Background: Down-expression of microRNA-497 (miR-497) was often found in malignancies. The purposes of this study were to determine the expression of miR-497 in human osteosarcoma and to establish the association between miR-497 expression with cell survival and the sensitivity to cisplatin in human osteosarcoma cells. Methods: The effects of ectopic miR-497 expression on the cell survival and cisplatin sensitivity in osteosarcoma cells were measured by the Cell Counting Kit-8 (CCK-8) assay. Quantitative real-time PCR (qRT-PCR) was utilized to determine the expression of miR-497. The effects of ectopic miR-497 expression on the expression of VEGFA, Akt and p-Akt were determined by western blot. Results: Real-time quantitative PCR analysis revealed that miR-497 was significantly down-regulated in osteosarcoma tissues and in the osteosarcoma cell line SAOS-2 compared with adjacent nontumorous osteosarcoma tissues and normal human osteoblasts. Up-regulation of miR-497 inhibited cell survival and enhanced the sensitivity to cisplatin in osteosarcoma cells. In addition, knockdown of miR-497 induced osteosarcoma cells growth and cisplatin resistance. Luciferase reporter assay and western blot confirmed that VEGFA was a direct target of miR-497. PI3K inhibitor LY294002 abrogated miR-497 inhibitors induced cisplatin resistance. Conclusion: Taken together, our results suggest that miR-497 modulates the sensitivity to cisplatin at least in part through PI3K/Akt pathway in osteosarcoma cells.
first_indexed 2024-12-13T07:36:29Z
format Article
id doaj.art-70e5d4cb132442279172c730b1083ca9
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-13T07:36:29Z
publishDate 2015-07-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-70e5d4cb132442279172c730b1083ca92022-12-21T23:55:05ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782015-07-013652051206210.1159/000430172430172The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in OsteosarcomaXue-jun ShaoMei-hua MiaoJun XueJian XueXue-qiang JiHong ZhuBackground: Down-expression of microRNA-497 (miR-497) was often found in malignancies. The purposes of this study were to determine the expression of miR-497 in human osteosarcoma and to establish the association between miR-497 expression with cell survival and the sensitivity to cisplatin in human osteosarcoma cells. Methods: The effects of ectopic miR-497 expression on the cell survival and cisplatin sensitivity in osteosarcoma cells were measured by the Cell Counting Kit-8 (CCK-8) assay. Quantitative real-time PCR (qRT-PCR) was utilized to determine the expression of miR-497. The effects of ectopic miR-497 expression on the expression of VEGFA, Akt and p-Akt were determined by western blot. Results: Real-time quantitative PCR analysis revealed that miR-497 was significantly down-regulated in osteosarcoma tissues and in the osteosarcoma cell line SAOS-2 compared with adjacent nontumorous osteosarcoma tissues and normal human osteoblasts. Up-regulation of miR-497 inhibited cell survival and enhanced the sensitivity to cisplatin in osteosarcoma cells. In addition, knockdown of miR-497 induced osteosarcoma cells growth and cisplatin resistance. Luciferase reporter assay and western blot confirmed that VEGFA was a direct target of miR-497. PI3K inhibitor LY294002 abrogated miR-497 inhibitors induced cisplatin resistance. Conclusion: Taken together, our results suggest that miR-497 modulates the sensitivity to cisplatin at least in part through PI3K/Akt pathway in osteosarcoma cells.http://www.karger.com/Article/FullText/430172VEGFACisplatinOsteosarcomamicroRNA-497
spellingShingle Xue-jun Shao
Mei-hua Miao
Jun Xue
Jian Xue
Xue-qiang Ji
Hong Zhu
The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
Cellular Physiology and Biochemistry
VEGFA
Cisplatin
Osteosarcoma
microRNA-497
title The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
title_full The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
title_fullStr The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
title_full_unstemmed The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
title_short The Down-Regulation of MicroRNA-497 Contributes to Cell Growth and Cisplatin Resistance Through PI3K/Akt Pathway in Osteosarcoma
title_sort down regulation of microrna 497 contributes to cell growth and cisplatin resistance through pi3k akt pathway in osteosarcoma
topic VEGFA
Cisplatin
Osteosarcoma
microRNA-497
url http://www.karger.com/Article/FullText/430172
work_keys_str_mv AT xuejunshao thedownregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT meihuamiao thedownregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT junxue thedownregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT jianxue thedownregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT xueqiangji thedownregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT hongzhu thedownregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT xuejunshao downregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT meihuamiao downregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT junxue downregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT jianxue downregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT xueqiangji downregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma
AT hongzhu downregulationofmicrorna497contributestocellgrowthandcisplatinresistancethroughpi3kaktpathwayinosteosarcoma